Delivery Order SPE2DR25D1053-SPE2DR26FV063
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of IMBRUVICA 420 mg tablets (28-count packages) with a ceiling value of $7,983.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by January 15, 2026, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 280 mg tablets (28-count) with a ceiling value of $15,967.36 under a firm fixed-price contract. The award, issued on December 16, 2025, is set to conclude by January 8, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside delivery order that reflects the company's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of IMBRUVICA 420 mg tablets (28-count packages) with a ceiling value of $15,151.52. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,967.36 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count packaging) under a firm fixed-price contract. The award, made on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a non-competitive delivery order issued against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, for the supply of IMBRUVICA 280 mg tablets (28-count packaging) valued at $15,151.52. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 23, 2025. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) under a firm fixed price contract. This non-competitive set-aside delivery order is scheduled for completion by September 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services through AmerisourceBergen's extensive federal...
- The Defense Logistics Agency awarded a $7,983.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for IMBRUVICA 280MG tablets (28-count units) with an ultimate completion date of December 31, 2025. This non-set-aside, competitively awarded contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,983.68 for IMBRUVICA 280 MG tablets (28-count) under a firm fixed-price contract with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside delivery order represents a continuation of the company's pharmaceutical supply services to federal military and healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg tablets (28-count package) under a firm fixed-price contract. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV063Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of IMBRUVICA 420 mg tablets (28-count packages) with a ceiling value of $15,967.36. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract and is part of AmerisourceBergen's broader relationship with DLA as a critical pharmaceutical supplier. The contract is scheduled for ultimate completion on January 21, 2026, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceuticals and medical commodities to support military healthcare programs and serve customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order aligns with AmerisourceBergen's demonstrated capability in meeting federal medical procurement requirements through open competition and reflects the company's extensive portfolio of specialty medications and brand-name drugs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 12/28/25 |